332 related articles for article (PubMed ID: 26280784)
1. The Role of RAAS Inhibition by Aliskiren on Paracetamol-Induced Hepatotoxicity Model in Rats.
Karcioglu SS; Palabiyik SS; Bayir Y; Karakus E; Mercantepe T; Halici Z; Albayrak A
J Cell Biochem; 2016 Mar; 117(3):638-46. PubMed ID: 26280784
[TBL] [Abstract][Full Text] [Related]
2. What is the role of renin inhibition during rat septic conditions: preventive effect of aliskiren on sepsis-induced lung injury.
Akpinar E; Halici Z; Cadirci E; Bayir Y; Karakus E; Calik M; Topcu A; Polat B
Naunyn Schmiedebergs Arch Pharmacol; 2014 Oct; 387(10):969-78. PubMed ID: 25005757
[TBL] [Abstract][Full Text] [Related]
3. Potential protective effect of honey against paracetamol-induced hepatotoxicity.
Galal RM; Zaki HF; Seif El-Nasr MM; Agha AM
Arch Iran Med; 2012 Nov; 15(11):674-80. PubMed ID: 23102243
[TBL] [Abstract][Full Text] [Related]
4. Inhibiting renin angiotensin system in rate limiting step by aliskiren as a new approach for preventing indomethacin induced gastric ulcers.
Halici Z; Polat B; Cadirci E; Topcu A; Karakus E; Kose D; Albayrak A; Bayir Y
Chem Biol Interact; 2016 Oct; 258():266-75. PubMed ID: 27645307
[TBL] [Abstract][Full Text] [Related]
5. The role of infliximab on paracetamol-induced hepatotoxicity in rats.
Ferah I; Halici Z; Bayir Y; Demirci E; Unal B; Cadirci E
Immunopharmacol Immunotoxicol; 2013 Jun; 35(3):373-81. PubMed ID: 23496246
[TBL] [Abstract][Full Text] [Related]
6. [Does the rennin inhibitor aliskiren offer promising novel opportunities in the treatment of cardiovascular diseases?].
Horký K
Vnitr Lek; 2007 Apr; 53(4):364-70. PubMed ID: 17578167
[TBL] [Abstract][Full Text] [Related]
7. Aliskiren - a promising strategy for ovarian ischemia/reperfusion injury protection in rats via RAAS.
Bayir Y; Cadirci E; Polat B; Kilic Baygutalp N; Albayrak A; Karakus E; Un H; Keles MS; Kocak Ozgeris FB; Toktay E; Karaca M; Halici Z
Gynecol Endocrinol; 2016 Aug; 32(8):675-683. PubMed ID: 26939623
[TBL] [Abstract][Full Text] [Related]
8. Protective effect of Et-1 receptor antagonist bosentan on paracetamol induced acute liver toxicity in rats.
Yayla M; Halici Z; Unal B; Bayir Y; Akpinar E; Gocer F
Eur J Pharmacol; 2014 Mar; 726():87-95. PubMed ID: 24462570
[TBL] [Abstract][Full Text] [Related]
9. The effects of apomorphine on paracetamol-induced hepatotoxicity in rats.
Sehitoglu MH; Yayla M; Kiraz A; Oztopuz RO; Bayir Y; Karaca T; Khalid S; Akpinar E
Cell Mol Biol (Noisy-le-grand); 2017 Dec; 63(12):40-44. PubMed ID: 29307340
[TBL] [Abstract][Full Text] [Related]
10. Renoprotective effect of aliskiren on renal ischemia/reperfusion injury in rats: electron microscopy and molecular study.
Ziypak T; Halici Z; Alkan E; Akpinar E; Polat B; Adanur S; Cadirci E; Ferah I; Bayir Y; Karakus E; Mercantepe T
Ren Fail; 2015 Mar; 37(2):343-54. PubMed ID: 25524622
[TBL] [Abstract][Full Text] [Related]
11. Protective effect of an L-type calcium channel blocker, amlodipine, on paracetamol-induced hepatotoxicity in rats.
Kaya H; Polat B; Albayrak A; Mercantepe T; Buyuk B
Hum Exp Toxicol; 2018 Nov; 37(11):1169-1179. PubMed ID: 29441826
[TBL] [Abstract][Full Text] [Related]
12. Effects of renin-angiotensin-aldosterone system blockade on chlorhexidine gluconate-induced sclerosing encapsulated peritonitis in rats.
Koçak G; Azak A; Astarcı HM; Huddam B; Karaca G; Ceri M; Can M; Sert M; Duranay M
Ther Apher Dial; 2012 Feb; 16(1):75-80. PubMed ID: 22248199
[TBL] [Abstract][Full Text] [Related]
13. The Effects of RAAS Inhibition in Rate Limiting Step by Aliskiren on Testicular Torsion Injury in Rats.
Un H; Bayir Y; Halici Z; Akpinar E; Karakus E; Oral A; Ziypak T; Selli J
J Urol; 2015 Sep; 194(3):828-33. PubMed ID: 25849601
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of the renin angiotensin aldosterone system: focus on aliskiren.
Rao MS
J Assoc Physicians India; 2010 Feb; 58():102-8. PubMed ID: 20653151
[TBL] [Abstract][Full Text] [Related]
15. Antioxidative and Protective Actions of Apigenin in a Paracetamol-Induced Hepatotoxicity Rat Model.
Rašković A; Gigov S; Čapo I; Paut Kusturica M; Milijašević B; Kojić-Damjanov S; Martić N
Eur J Drug Metab Pharmacokinet; 2017 Oct; 42(5):849-856. PubMed ID: 28255865
[TBL] [Abstract][Full Text] [Related]
16. Carnitine deficiency: a possible risk factor in paracetamol hepatotoxicity.
Arafa HM
Arch Toxicol; 2009 Feb; 83(2):139-50. PubMed ID: 18597074
[TBL] [Abstract][Full Text] [Related]
17. New insights into the renoprotective actions of the renin inhibitor aliskiren in experimental renal disease.
Feldman DL
Hypertens Res; 2010 Apr; 33(4):279-87. PubMed ID: 20203685
[TBL] [Abstract][Full Text] [Related]
18. [Direct renin inhibitor aliskiren in the treatment of cardiovascular and renal diseases].
Horký K
Vnitr Lek; 2010 Feb; 56(2):120-6. PubMed ID: 20329582
[TBL] [Abstract][Full Text] [Related]
19. Direct inhibition of renin as a cardiovascular pharmacotherapy: focus on aliskiren.
Sepehrdad R; Frishman WH; Stier CT; Sica DA
Cardiol Rev; 2007; 15(5):242-56. PubMed ID: 17700383
[TBL] [Abstract][Full Text] [Related]
20. Direct renin inhibition in addition to or as an alternative to angiotensin converting enzyme inhibition in patients with chronic systolic heart failure: rationale and design of the Aliskiren Trial to Minimize OutcomeS in Patients with HEart failuRE (ATMOSPHERE) study.
Krum H; Massie B; Abraham WT; Dickstein K; Kober L; McMurray JJ; Desai A; Gimpelewicz C; Kandra A; Reimund B; Rattunde H; Armbrecht J;
Eur J Heart Fail; 2011 Jan; 13(1):107-14. PubMed ID: 21169387
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
